<?xml version="1.0" encoding="UTF-8"?>
<p id="p0180">Mitochondrial dysfunction, for example, due to aging or chronic disease, negatively affects immunity and inflammation (
 <xref rid="bib72" ref-type="bibr">McGuire, 2019</xref>) and is a potential risk factor for SARS-CoV-2 infection. Mitochondrial integrity is paramount to mount adequate antiviral defense and prevent viral manipulation. Mitochondrial membrane potential, an important indicator of mitochondrial integrity, and oxidative phosphorylation have been shown to be necessary for the activation of the RLR-MAVS pathways (
 <xref rid="bib60" ref-type="bibr">Koshiba et al., 2011</xref>; 
 <xref rid="bib130" ref-type="bibr">Yoshizumi et al., 2017</xref>). Moreover, the viral inhibition of MAVS by, e.g., the influenza virus protein PB1-F2 is achieved by a reduction of mitochondrial membrane potential (
 <xref rid="bib118" ref-type="bibr">Varga et al., 2012</xref>; 
 <xref rid="bib129" ref-type="bibr">Yoshizumi et al., 2014</xref>). Supporting these results, diminished mitochondrial membrane potential is associated with a lower cytokine production after infection with various viruses (
 <xref rid="bib48" ref-type="bibr">Ichinohe et al., 2013</xref>) and functional mitochondrial respiration is required to activate specialized immune cells (
 <xref rid="bib92" ref-type="bibr">Sander and Garaude, 2018</xref>).
</p>
